Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $95.01 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $27.65 | 1 | $0 (2017) |
| Amgen Inc. | $25.55 | 1 | $0 (2017) |
| Promius Pharma LLC | $16.14 | 1 | $0 (2017) |
| PFIZER INC. | $14.18 | 1 | $0 (2017) |
| Genentech USA, Inc. | $11.49 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $95.01 | 5 | Regeneron Healthcare Solutions, Inc. ($27.65) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2017 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Inflammation | ||||||
| 07/26/2017 | Promius Pharma LLC | Sernivo Spray 120ml (Drug), Trianex, Cloderm Cream | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Neurology | ||||||
| 06/27/2017 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/07/2017 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: BioOncology | ||||||
| 01/30/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,519 | 7,296 | $1.7M | $629,212 |
| 2022 | 33 | 4,771 | 7,661 | $1.8M | $688,030 |
| 2021 | 31 | 4,584 | 7,876 | $1.7M | $655,728 |
| 2020 | 31 | 4,259 | 7,283 | $1.7M | $621,455 |
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 315 | 388 | $440,429 | $167,813 | 38.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 204 | 304 | $209,099 | $95,059 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 911 | 981 | $148,773 | $53,216 | 35.8% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 69 | 78 | $83,170 | $37,827 | 45.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 488 | 555 | $94,083 | $36,860 | 39.2% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 64 | 64 | $82,429 | $36,260 | 44.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 724 | 902 | $101,302 | $33,625 | 33.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 127 | 140 | $71,300 | $23,136 | 32.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 82 | 87 | $68,901 | $15,999 | 23.2% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 39 | 49 | $32,328 | $14,822 | 45.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 223 | 223 | $41,889 | $14,106 | 33.7% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 23 | 23 | $29,276 | $13,073 | 44.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 514 | 2,705 | $30,177 | $12,494 | 41.4% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 15 | 15 | $23,149 | $10,454 | 45.2% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 44 | 44 | $36,700 | $8,434 | 23.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 168 | 176 | $16,640 | $6,416 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 75 | $16,124 | $6,137 | 38.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 35 | 38 | $20,146 | $4,868 | 24.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 37 | 40 | $11,304 | $4,558 | 40.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 42 | 45 | $11,138 | $4,464 | 40.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 33 | $9,877 | $4,192 | 42.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 42 | 43 | $17,625 | $4,048 | 23.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 21 | 22 | $15,731 | $3,606 | 22.9% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 25 | 28 | $14,561 | $3,341 | 22.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 70 | 83 | $6,977 | $2,971 | 42.6% |
About Dr. Thomas Braza, MD
Dr. Thomas Braza, MD is a MOHS-Micrographic Surgery healthcare provider based in Leland, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699883124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Braza, MD has received a total of $95.01 in payments from pharmaceutical and medical device companies, with $95.01 received in 2017. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($95.01).
As a Medicare-enrolled provider, Braza has provided services to 18,133 Medicare beneficiaries, totaling 30,116 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties MOHS-Micrographic Surgery
- Location Leland, NC
- Active Since 08/25/2006
- Last Updated 11/01/2021
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1699883124
Products in Payments
- DUPIXENT DUPILUMAB INJECTION (Biological) $27.65
- Enbrel (Biological) $25.55
- Sernivo Spray 120ml (Drug) $16.14
- EUCRISA (Drug) $14.18
- Erivedge (Biological) $11.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.